Thank you for your interest in supporting Kaiser Health News (KHN), the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support.

KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can support KHN by making a contribution to KFF, a non-profit charitable organization that is not associated with Kaiser Permanente.

Click the button below to go to KFF’s donation page which will provide more information and FAQs. Thank you!



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Why are teens trying them?

Michelle Roberts Digital health editor, BBC News Getty Images A growing number of US teenagers are using caffeine pouches to get an energy rush, say experts who worry the trend

Structure dictates effectiveness, safety in nanomedicine

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The specific location of each atom within the drug molecule is a critical factor

Research using non-toxic bacteria to fight high-mortality cancers prepares for clinical trials

A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made “exciting,” patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging